BIOVENTUS_LOGO.png
BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration
October 18, 2021 08:00 ET | Bioventus, Inc.
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), today announced an election deadline of 5:00 p.m.,...
BIOVENTUS_LOGO.png
DUROLANE® Among High-Molecular Weight Hyaluronic Acid Treatments Linked to Significant Improvements in Knee Osteoarthritis Pain by American Academy of Orthopaedic Surgeons
September 20, 2021 08:30 ET | Bioventus, Inc.
DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc., (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in innovations for active healing, announced that the American Academy of...
BIOVENTUS_LOGO.png
Bioventus Proceeds with Option Structure Agreement with CartiHeal
August 30, 2021 07:30 ET | Bioventus, Inc.
DURHAM, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has elected to make a $50 million...
BIOVENTUS_LOGO.png
Bioventus Invests in Trice Medical Minimally Invasive Technologies
August 25, 2021 16:05 ET | Bioventus, Inc.
DURHAM, N.C., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed a strategic investment...
BIOVENTUS_LOGO.png
Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer
August 23, 2021 08:30 ET | Bioventus, Inc.
DURHAM, N.C., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has appointed Dave Crawford as its...
BIOVENTUS_LOGO.png
Bioventus Reports Second Quarter Results; Updates Full Year 2021 Financial Guidance
August 10, 2021 16:05 ET | Bioventus, Inc.
DURHAM, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
BIOVENTUS_LOGO.png
Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix
July 29, 2021 16:05 ET | Bioventus, Inc.
Significantly Expands TAM and Adds Considerable Scale and Scope in Spine and Lower ExtremityEnhances Surgical Solutions Vertical by Adding Minimally Invasive Ultrasonic Technologies That Improve...
BIOVENTUS_LOGO.png
Bioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales Guidance
July 29, 2021 16:00 ET | Bioventus, Inc.
DURHAM, N.C., July 29, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported preliminary financial...
BIOVENTUS_LOGO.png
Bioventus® Management to Present at Canaccord Genuity Growth Conference and Morgan Stanley Virtual Global Healthcare Conference
July 27, 2021 16:15 ET | Bioventus, Inc.
DURHAM, N.C., July 27, 2021 (GLOBE NEWSWIRE) -- Senior management of Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, will present at...
Bioventus Appoints Mary Kay Ladone to Board of Directors
July 14, 2021 16:05 ET | Bioventus, Inc.
DURHAM, N.C., July 14, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has announced the appointment of Mary...